What We Monitor for Quality & Compliance
CGMP enforcement & warning letters
Inspection observation patterns
QSR/QMSR modernization
Data integrity requirements
Process validation guidance
CAPA and deviation expectations
Supplier qualification standards
Computer system validation (CSA)
Recall and field action trends
Decisions This Intelligence Affects
QMS Program Priorities
- • Quality system improvement focus
- • Resource allocation decisions
- • Training program development
- • SOP update prioritization
Inspection Readiness
- • Mock audit focus areas
- • Documentation review priorities
- • Response preparation
- • Management review topics
Risk Management
- • Compliance risk assessment
- • Supplier risk prioritization
- • CAPA effectiveness evaluation
- • Product quality risk inputs
Leadership Communication
- • Compliance status reporting
- • Resource justification
- • Risk escalation framing
- • Board and investor updates
How Quality Leaders Use This Intelligence
Anticipate Enforcement Shifts
Detect warning letter patterns before your next inspection
Prioritize QMS Improvements
Focus resources on areas FDA is emphasizing
Reduce Research Time
Pre-interpreted guidance saves 10+ hours per major update
Prepare for Inspection Trends
Know what FDA inspectors are focusing on now
Justify Compliance Investment
Cite regulatory context in resource requests
Support Audit Defense
Document regulatory rationale in quality decisions